Malecki Brooks Ford Law Group, LLC

Malecki Brooks Ford Law Group, LLC Malecki Brooks Ford Law Group, LLC 2026-09-29T22:47:09Z https://www.mbhealthlaw.com/feed/atom/ WordPress /wp-content/uploads/sites/1504063/2024/05/cropped-ID-image-2-32x32.jpg On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[Through a New Lens: The Future of Smart Glasses in Healthcare]]> https://www.mbhealthlaw.com/?p=51148 2026-08-25T14:17:55Z 2026-08-25T14:17:55Z

Healthcare evolves alongside technology, and the next major shift may be happening literally in front of our eyes. We are talking about smart glasses.

What are smart glasses?

Smart glasses, like “Meta” glasses, are glasses that blend everyday style with powerful technology. Unlike typical glasses, smart glasses offer hands-free control to capture images and videos, provide real-time information, and support voice commands. With a simple command you can ask AI a question, to play a song, send a message, or look at what you are pointing to and have it described. In healthcare, potential uses include:

Hands-free clinical documentation: Providers can use voice commands to dictate notes or capture key findings.
Workflow: Allows providers to access information without repeatedly using computers.
Real-time expert assistance: Could connect a city specialist with a rural specialist who can view the situation in real time and provide advice, improving access to care.
AI-Driven diagnostics: Providers can capture a photo of a patient’s physical symptom and prompt AI to analyze the image and provide insight.

Why are they relevant now in healthcare?

Smart glasses have the potential to change how providers document care and communicate with teams. However, they raise important questions about privacy and security.

What could go wrong?

Patient privacy and HIPAA: May increase the risk of privacy breaches if PHI is recorded or shared improperly whether it be by providers, staff, patients, or visitors.
Unauthorized recording: Cameras and microphones may capture patients or staff without their knowledge.
Cybersecurity: Stored data may be accessed without authorization.
Patient consent: Patients should understand when and how the technology is being used. Some models of smart glasses have indications (like a LED light) that shows when a video or photo is being taken. It can be disabled, making it difficult for someone unfamiliar with this technology to recognize what is happening.
Distractions: Overreliance on technology could have a negative impact on provider-patient relationships or increase medical errors.

What can healthcare organizations do?

The answer is not to reject innovation, but to implement it responsibly.

- Develop and update policies on the use of smart glasses and the possible restriction of use by patients and visitors.
- Train staff and leaders on privacy, responsible use, expectations, and any restrictions regarding the use of these devices.
- Conduct regular privacy and security audits to identify and address potential risks.

Implement technical safeguards, like encryption.

Smart glasses have the potential to improve healthcare, but organizations must balance innovation with patient privacy, security, and trust. By implementing thoughtful polices and safeguards, healthcare organizations can embrace new technologies and protect the patients they serve. We can help.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[What to consider before leaving or being let go from a practice]]> https://www.mbhealthlaw.com/?p=51146 2026-08-18T14:12:18Z 2026-08-18T14:12:18Z

Leaving a medical practice, or being let go from one, is a big change. This is true whether you are a doctor, nurse practitioner, or other healthcare provider working in Chicago. Before you make a move, or react to being terminated, it helps to slow down and think through a few key issues. Doing this can protect your career, your patients, and your peace of mind.

Reviewing your employment contract

The first step is to read your contract closely. Most practices in Chicago use written agreements that spell out notice periods, severance pay, and what happens to patient records when someone leaves. Some contracts also include non-compete clauses, which limit where you can work after you go. Illinois law places some restrictions on these clauses, especially for lower-paid workers, but they can still affect physicians and other licensed providers. Look for language about how much notice you must give, whether you owe any money back to the practice, and what your rights are if the practice ends your job without cause. If any part of the contract feels unclear, write down your questions before you take any next steps.

Understanding your duties to patients

Under the Illinois Medical Practice Act, failing to provide patients with adequate written notice and continuity-of-care arrangements when leaving a practice constitutes patient abandonment, which can result in formal disciplinary action against a practitioner's license. Chicago practices may have their own policies about how and when this notice goes out. There can also be rules about transferring medical records safely and on time. Ignoring these duties, even by accident, can lead to complaints or licensing problems later.

Talking with an attorney

Every situation is a little different, and small details in a contract or in state rules can change what options are available. Talking with an attorney who knows Illinois healthcare and employment law may offer clarity during a stressful time. They can look over the contract, explain what the notice and non-compete terms actually mean, and help make sure the transition is handled fairly for everyone involved, including patients.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[DEA Impersonation Scams Targeting Healthcare Providers]]> https://www.mbhealthlaw.com/?p=51136 2026-08-05T18:07:24Z 2026-08-04T20:31:13Z

We want to ensure our clients are aware of an ongoing scam where fraudsters impersonate the Drug Enforcement Administration (DEA) to target physicians, pharmacists, and other DEA registrants. The DEA has issued repeated public warnings about this scheme, and it continues to evolve. Here’s what to watch out for and what to do if you're contacted.

What's happening

Scammers are contacting healthcare providers by phone and by letter, sometimes even on official-looking Department of Justice letterhead. These letters and messages falsely claim that the recipient is under investigation, typically for unlawful prescribing or distribution of controlled substances. Both DEA-registered and non-registered physicians have been targeted. The goal of the fraudsters is to obtain personal or financial information, or to extort a payment. These callers attempt to sound credible by:

Using the real names of well-known DEA officials, retired agents, or local police officers
Providing a fake badge number, often recited immediately at the start of the call
Referencing your National Provider Identifier (NPI) number or state license number, information that is publicly available, not proof the caller is legitimate
Claiming patients have made accusations against you, or that your DEA registration or medical license is under investigation
Using an urgent, aggressive tone and threatening arrest, prosecution, imprisonment, or revocation of your DEA registration or medical license

Eventually, callers ask for sensitive information such as a Social Security number, date of birth, bank account details. They may even demand payment to resolve the supposed “investigation.”

What the DEA actually does and doesn't do

The DEA has confirmed the following, which should help you recognize a scam call or letter immediately:

The DEA does not call registrants about investigations. Legitimate DEA personnel will only notify someone of an investigation or legal action in person or by official letter.
The DEA will never demand money, gift cards, wire transfers, or any other form of payment over the phone.
The DEA will never ask for your Social Security number, date of birth, or other sensitive personal information by phone.
The DEA does not investigate or revoke medical licenses. That authority belongs to state medical boards. A caller who threatens to “revoke your medical license” is not from the DEA.
DEA personnel are titled Special Agents or Diversion Investigators, not “officers.” A caller who identifies themselves as an “Officer” with the “DEA Drug Enforcement Administration” (a redundant phrase a real agent would not use) is a red flag on its own.

What to do if you receive one of these calls or letters

Do not engage. Do not confirm your identity, provide any personal or professional information (including your DEA registration number, NPI, Social Security number, date of birth, or banking details), or make any payment.
Do not call back any number the caller provides. If you want to verify a communication, look up the DEA's number independently rather than using contact information supplied in the suspicious call or letter.
Hang up or set the letter aside and contact our office if you're unsure if the communication is legitimate. We're glad to help you evaluate it before you respond.
Report the incident. You can report scam calls to the FBI's Internet Crime Complaint Center at ic3.gov, to the Federal Trade Commission at reportfraud.ftc.gov, and to the DEA's Diversion Control hotline at 1-877-792-2873.

If you’ve already shared information or made a payment

If you provided a Social Security number, bank account information, or other sensitive data, or sent a payment, act quickly:

Contact your bank or credit card issuer immediately to flag the account and, if you shared a card number, treat it as lost or stolen.
Consider placing a temporary credit freeze with the three major credit bureaus to prevent new accounts being opened in your name.
Visit identitytheft.gov for a personalized recovery plan.
Let our office know. Depending on what was disclosed, there may be additional steps worth taking to protect your DEA registration, NPI, and professional standing.

Related risks to consider

Treat your DEA registration number and NPI as sensitive credentials, not public reference numbers, even though both can be looked up online. If you ever notice prescribing activity you don't recognize under your name or registration, contact us right away, this could implicate your DEA registration and requires prompt attention. Some physicians have also reported a related scam involving callers who claim to be with the Centers for Medicare & Medicaid Services (CMS), demanding medical records or payment of an alleged Medicare debt. The same rule applies: legitimate government agencies do not demand immediate payment or sensitive information over the phone.

Key considerations before forming your PLLC

Before you move forward with starting a PLLC, you should think about several important factors. Your malpractice insurance needs may change based on your business structure. You will also need to make sure you keep proper licensing with the Illinois Department of Financial and Professional Regulation. Additionally, forming a PLLC involves ongoing tasks you must complete:

Filing yearly reports with the state
Keeping separate business bank accounts
Keeping detailed business records
Following proper business rules

These requirements take time and attention beyond your patient care duties.

Moving forward with confidence

Choosing the right business structure for your medical practice is a major decision that could affect your financial future and professional liability. While a PLLC offers potential benefits for Illinois physicians, the formation process and ongoing tasks deserve careful thought. You are not alone in working through these complex decisions. Talking with professionals who understand both Illinois business law and healthcare rules can provide helpful guidance tailored to your specific situation. Taking the time to explore your options carefully now can help you build a strong foundation for your practice's future success.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[CAN YOU KEEP A SECRET? JUST SIGN HERE.]]> https://www.mbhealthlaw.com/?p=51066 2026-07-07T19:38:46Z 2026-07-07T19:38:46Z

What the Taylor Swift/Travis Kelce wedding can teach us about NDAs As an attorney I am used to dealing with confidential information. So much so that I am conditioned to treat just about everything as confidential, including what comes and goes in my personal life. If a friend tells me something, I presume it’s confidential until told otherwise. Conversely, I don’t presume that what I tell people will be kept confidential, so I carefully choose when to share private information, limiting those disclosures. This approach has worked for me professionally and personally for a long time, and I never gave it much thought. Last weekend, I kept checking my phone for updates on the secret Swift-Kelce wedding because I'm a huge fan of Taylor Swift and admire her talent and business savvy. I was hoping—and frankly expecting—that I would catch a glimpse of the secret event. I told myself that surely there would be something shared with their fans, a photo of them, the décor, something. And that’s when I thought: Did the nondisclosure agreements (NDAs) that the guests and staff reportedly signed really work? It certainly looks like they did. Taylor Swift and her husband may have started a trend by bringing the legality of an NDA into a social context. It’s such an interesting concept that I am unable to “shake it off.” Is it too crazy to consider using NDAs in our personal relationships? For example, if I tell my close friend a secret and tell her not to repeat it, do I just trust that she won’t, or do I ask her to sign an NDA? Would I sue her if she violates? What about asking her to sign an NDA about our friendship in general and consider everything confidential unless otherwise stated? The questions are endless but not entirely unreasonable. But before I start drafting NDAs for my friendships, though, it's worth stepping back to look at what an NDA is, when they are typically used in a legal setting, and what can happen if someone violates or “breaches” the NDA.

What is a Nondisclosure Agreement (NDA)?

In general, a Nondisclosure Agreement (NDA) is a formal, enforceable contract. It is designed to ensure that confidential information remains private. As a contract, it defines the responsibilities of the parties involved and provides legal remedies if the agreement is violated.

When is an NDA appropriate?

Typically, NDAs are used in business situations to protect the confidential information of parties to a transaction. This could include information shared by one party with another party that is trying to determine whether/how to proceed with a transaction. If you are thinking about buying a business and want to review information pertinent to that before you commit, an NDA would be appropriate for you to review and possibly sign, subject to the advice of your attorney.

If you “spill the beans” and violate an NDA, what are the legal consequences?

Technically, the legal complaint against you would be for a “breach of contract.” If you are found to be in breach, you could be liable for monetary damages caused by your breach. If disclosure of confidential information caused harm to another party to which you promised confidentiality, you could be liable to pay those damages. Whether or not Taylor and Travis have started a new trend, the legal value of an NDA, lies more in the threat of a lawsuit and less in trusting the people we let in. So the next time a friend tells me something in confidence, I'll keep presuming it's private. But we all might start wondering if we need better terms. Dinner at my house? For further information contact: Melinda Malecki mmalecki@mbhealthlaw.com ]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[Understanding ‘for cause’ and ‘without cause’ terminations]]> https://www.mbhealthlaw.com/?p=51044 2026-04-28T05:48:43Z 2026-04-28T05:48:43Z

end the relationship at any time if the reason is not illegal. This issue appears often in physician and provider agreements, especially when contracts include termination clauses that shape job security. So what does this mean when you review your terms?

Distinguishing for cause and without cause termination

The type of termination clause sets the level of protection in your agreement, which directly affects your position. “For cause” termination depends on specific reasons listed in the contract, such as policy violations, conduct issues or defined performance concerns. These terms can limit when an employer may end the agreement. “Without cause” termination allows either party to end the relationship without giving a reason, which reflects the at-will nature of many Illinois jobs. However, a contract may change that default by requiring cause or setting conditions. The difference often centers on whether the employer must justify the decision.

Assessing contract terms that define notice and risk

Certain contract terms outline the steps and conditions tied to ending the agreement, which often affect timing and planning. Review these key provisions:

Notice period length
Cure period for alleged issues
Definition of cause in the agreement
Impact on pay and benefits
Patient transition responsibilities

Each term can influence stability, which means small wording differences may affect your position.

When does a termination clause raise concern?

A termination clause raises concern when the language allows sudden separation without clear timing or defined steps, which can disrupt your role and patient care. You might notice this during contract review when notice terms, listed causes or cure periods do not align. At that point, it helps to pause, compare those sections closely and consider how each term affects your schedule, income flow and patient handoffs if the relationship ends.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[How much negotiating is too much on your employment agreement?]]> https://www.mbhealthlaw.com/?p=51014 2026-02-24T10:58:14Z 2026-02-24T10:39:14Z

You might feel tempted to sign your first medical job offer as soon as it hits your inbox, especially after years of training, debt and exams. The firm McDonald Hopkins shares some thoughtful cautions about how far you may want to push in negotiations and where to ease up, which you can read more about here.

Why new physicians often hesitate

Many new physicians feel grateful for an offer and worry that negotiating could make the employer lose interest. You might also assume that a contract is standard and therefore fair, or that the employer knows what is reasonable. These assumptions can discourage you from raising important points. At the same time, failing to address key concerns could affect your schedule, compensation and long-term options.

Signs you may be pushing too hard

Negotiation can be productive, but it is possible to overextend. You might be moving into “too much” negotiation if you notice:

Requesting changes to almost every section of the agreement instead of focusing on top priorities
Sending long lists of edits in multiple rounds without distinguishing what matters most
Insisting on terms that are far outside local or specialty norms, especially regarding salary or call duties
Ignoring clear signals that the employer has reached its limit on certain issues

Focusing on a few core concerns often allows you to protect your interests without creating unnecessary friction.

Areas worth focusing on

Most new physicians benefit from concentrating on terms that influence daily work and long-term risk. Key areas may include:

Compensation structure and realistic earning potential over time
Call schedule, clinic hours and expectations for weekends or holidays
Non-compete clauses or other restrictions on working elsewhere afterward
Malpractice coverage, including responsibility for tail coverage
Termination provisions and required notice to leave

Spending your negotiation energy on these points can make it easier to accept less negotiable clauses. You might also explore revisiting certain terms after working in the position for a period, instead of attempting to secure every change upfront.

How to negotiate without straining relationships

Tone can matter as much as content. Employers often respond better when you remain polite, curious and clear about your priorities. You could express excitement for the position while noting a desire to ensure a fair arrangement on key points. Framing discussions as questions rather than demands can help maintain goodwill. It may also help to consult with an experienced healthcare attorney to review the agreement. They can provide perspective on what is realistic in your market and help you balance thoroughness with approachability.

Finding a balanced approach

Your first employment contract can shape your income, schedule and options for years. Taking a measured approach that mixes reasonable negotiation with realistic expectations can help you accept an offer that protects your interests, supports your goals, and begins your working relationship on a positive note. A thoughtful approach can make signing your first contract feel more like a strategic choice rather than a leap of faith.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[4 ways you can beat impostor syndrome during contract negotiations]]> https://www.mbhealthlaw.com/?p=50994 2026-03-12T20:47:02Z 2025-12-22T16:36:34Z

As a woman in medicine, you may face contract negotiations while battling self-doubt. This is where impostor syndrome can make you feel unworthy of a better deal, even when the offer is unfavorable or below market value. Too often, physicians feel that they do not deserve to or are afraid to try to negotiate a better deal than what is initially presented. The good news is that you can overcome these feelings. Here are four ways to negotiate with confidence:

1. Highlight your brand

First, recognize the value you bring to the table. Whether it is your specialized skills, unique experiences, or a high demand for your role, these attributes are your leverage in negotiations. Imposter syndrome hits women hard, especially during high-stakes moments like contract negotiations. Do not let self-doubt overshadow your accomplishments. Think about how your expertise can help grow your employer's practice. When you own your strengths, you build a stronger case for better terms.

2. Don’t be afraid to be difficult

Once you know your worth, make sure others hear it too. Many women hesitate to push back during negotiations because they worry about seeming difficult. However, very rarely will an employer back out of an offer if demands are well thought out and reasonably justified. Research compensation data through professional associations. Come prepared with facts. Speaking up is not aggressive, it is professional.

3. Fight for what matters to you

Of course, compensation is just one piece of the puzzle. If parental leave is important to you, it should be discussed and addressed in writing, preferably in the final employment contract. The same applies to flexible scheduling, PTO policies or call schedules. Write down your priorities beforehand. Then advocate for them directly.

4. Get professional legal help

Finally, consider bringing in an expert. Understanding physician contracts and employment agreements on your own is a daunting task. Just as patients trust you with their health, you should trust a legal professional with your contract. An attorney can advocate for fair compensation, meaningful benefits and work conditions that align with industry standards. The cost of a contract review is often smaller compared to the risks involved. You protect your patients every day. Now, let a professional legal help protect your career.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[Key Open Questions and What Providers and Suppliers Should Be Doing Now]]> https://www.mbhealthlaw.com/?p=50992 2025-12-17T21:51:25Z 2025-12-17T21:51:25Z

In our earlier article, we broke down the key elements of Final Rule CMS–1828–F and what it means for the future of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (CBP). But as many in the industry have pointed out, understanding the rule itself is only half the story. After years without a fully active bidding cycle, CMS has laid out a renewed framework, yet many details remain unresolved. image of a statoscope

As organizations assess these changes, new questions emerge about how they will be implemented. Ahead of the next competitive bidding cycle, stakeholders are trying to balance what CMS has finalized with what remains unclear. The return of competitive bidding arrives at a moment when hospitals, clinics, and suppliers are facing increased cost pressures, renewed CMS oversight, and growing patient demand for chronic-use products. Understanding what CMS–1828–F includes and what it leaves unaddressed is essential as organizations prepare for a reimbursement and regulatory environment that may look considerably different by 2028. Bid evaluation criteria present additional unknowns. While CMS updated pricing methodologies and bid ceilings, the agency has not specified how non-price factors—such as supplier capacity, geographic coverage, financial stability, or historical performance—will influence bid scoring. Stakeholders also want to know whether CMS intends to maintain broad supplier networks or adopt a more limited set of contract suppliers, as this decision will have direct implications for market competition and beneficiary access.

Questions Leaders Should Be Asking Now

When organizations evaluate how to prepare for CMS–1828–F, leadership teams should:

Assess their dependency on categories likely to enter competitive bidding

Evaluate whether existing suppliers have the capacity for national or regional distribution under RID-CBP
Understand the financial impact of potential 10%–20% reimbursement changes
Develop transition plans for chronic-use patient populations who may be required to switch suppliers

Addressing these issues early allows organizations to identify vulnerabilities, anticipate market changes, and build informed strategies before CMS releases additional guidance. In its recent Q&A resource, CMS addressed questions about the shift to annual accreditation surveys under CMS–1828–F, offering added clarity on survey expectations, timing, and year-round documentation requirements. While the guidance allows accreditation organizations to streamline certain reaccreditation elements for consistently compliant suppliers, CMS makes clear that the annual cycle will be treated as a full survey—not a scaled-down or abbreviated review. This clarification is particularly important for smaller suppliers and federally funded clinics that may have limited administrative capacity. The Q&A reiterates the need for continuous readiness, robust internal monitoring, and consistent adherence to quality and performance standards. The release of this resource signals CMS’s intention to implement uniform oversight practices while minimizing disruption during the transition to more frequent survey intervals.

Implications for Federally Funded Clinics

Federally funded health centers, including Federally Qualified Health Centers (FQHCs), rural health clinics, and public hospitals, may be disproportionately affected as CMS–1828–F is implemented. These providers serve high volumes of patients who rely on chronic-use supplies, often within constrained budgets and tightly managed supply chains. Supplier consolidation, narrower contract networks, and increased oversight could disrupt access and influence referral patterns, requiring clinics to reassess supplier relationships to maintain continuity of care for medically underserved populations.

Uncertainty Around Product Categories

A central area of uncertainty involves which product categories CMS plans to include in the upcoming bidding round. Although CMS–1828–F identifies several categories that could be competitively bid—such as continuous glucose monitors, insulin pumps, urological and ostomy supplies, hydrophilic catheters, and multiple off-the-shelf orthotic products—the agency has not confirmed which will ultimately appear on the final category list. For suppliers, this uncertainty may require preparing bids across multiple categories, adjusting inventories, or making early decisions about entering or exiting specific product lines. For hospitals and clinics, the stakes involve continuity of care and procurement strategy, because category selection directly affects which items may require contracting with competitively bid suppliers and how patient access could shift in the next cycle.

Operational Details for RID-CBP Remain Undefined

The operational framework for the Remote Item Delivery Competitive Bidding Program (RID-CBP) introduces a second layer of ambiguity. While the rule enables CMS to conduct bidding at a regional or national scale for items shipped directly to beneficiaries, it does not outline the performance standards or operational expectations suppliers will need to satisfy. Requirements related to delivery timeliness, documentation of shipment and receipt, inventory thresholds, and logistics capabilities have not yet been defined. Without clarity on these benchmarks, suppliers cannot fully assess whether they can or should participate in RID-CBP, nor can hospitals and clinics evaluate which suppliers are best positioned to meet patient needs under this emerging delivery model.

What These Unknowns Could Mean for the Market

Information on timing, exceptions, continuity-of-care expectations, and CMS support for transition logistics is unclear. While CMS has indicated that a transition period will occur once new contracts take effect, little detail is available on how beneficiaries, particularly those using chronic, high-utilization items, will be guided through supplier changes. Providers and suppliers alike require this information to plan patient communication, training, and access strategies. These uncertainties suggest a period of significant transition and adjustment for the DMEPOS sector. The shift toward national or regional bidding under RID-CBP may advantage suppliers with large-scale logistics infrastructure, potentially accelerating consolidation in the supplier market. New product categories, especially those with high utilization, may see downward pressure on reimbursement once Single Payment Amounts (SPAs) are established, influencing pricing strategies and product availability. Provider–supplier relationships are also expected to evolve as organizations evaluate whether current partners intend to bid, have the operational capacity to meet updated requirements, or are likely to secure contracts. Smaller suppliers may face challenges with annual accreditation, expanded financial reporting, and more complex logistics, while larger suppliers may pursue expansions or mergers to strengthen their competitive position. As the industry awaits additional details, CMS–1828–F clearly signals a significant shift in the competitive bidding framework. We encourage healthcare providers and suppliers to closely monitor CMS updates, engage early with emerging implementation requirements, and proactively address open questions ahead of the next competitive bidding round, expected no later than 2028. Early internal planning, supplier evaluations, and compliance readiness will be critical to navigating these forthcoming changes with greater clarity and confidence.]]> On Behalf of Malecki Brooks Ford Law Group, LLC <![CDATA[The End-of-Life Options for Terminally Ill Patients Act]]> https://www.mbhealthlaw.com/?p=50990 2026-01-26T18:13:51Z 2025-12-16T14:38:17Z

Illinois’ End-of-Life Options for Terminally Ill Patients Act image of a doc with a pen and notebook

(Please note: This Article has been updated and supersedes the original version previously published in the MBF newsletter. Revisions include clarification regarding the Right of Conscience Act, the duties of a health care entity that declines to provide aid in dying services, and enhanced definitions.) On December 12, 2025, Governor Pritzker signed Public Act 104-0441, the End-of-Life Options for Terminally Ill Patients Act, also known as “Deb’s Law” (“Act”). The Act does not go into effect until September 12, 2026. This delay in the effective date gives affected health care entities (“HCEs”) and health care professionals (“HCPs”) time to become familiar with the Act and to develop policies, procedures and forms to implement their obligations under the Act. This article provides a brief summary of some key provisions of the Act. The Act imposes obligations and confers rights on health providers regardless of whether they choose to participate in the new care option described in the Act. The Act provides a new option for end-of-life care that supplements existing care options such as palliative care, pain control, comfort care and hospice services, endeavoring to enable patients to choose an end-of-life experience that is aligned with their individual beliefs and values. The new option, referred to as “aid-in-dying” (“AID”), allows a “qualified patient” as defined in the Act, who has been diagnosed with a terminal illness expected to cause death within six months, to request that the patient’s attending physician prescribe medications that will likely result in the qualified patient’s death (“AID medications”), for self-administration by the patient. A “qualified patient” is an adult Illinois resident with mental capacity as defined in the Act who has satisfied the requirements of the Act to request a prescription for AID medications. The Act prescribes that a request for AID medications be directed to the attending physician, defined as the physician with primary responsibility for the care of the qualified patient and the treatment of the patient’s terminal illness. The request must be made both verbally and in a written document substantially in the form set forth in the Act. With certain exceptions, the patient must repeat the verbal request after waiting at least five days. After receiving the request, the attending physician must request an evaluation by a consulting physician for written confirmation that the patient has the required mental capacity and has a terminal illness with a prognosis of six months or less to live. If the attending physician or the consulting physician has any concerns regarding the patient’s mental capacity, the patient must be referred to a licensed mental health practitioner, as defined in the Act, for an evaluation and written determination whether the patient has the required mental capacity or suffers from a psychological or psychiatric disorder causing impaired judgment. Assuming that all requirements of the Act are met, the attending physician may prescribe, and a pharmacy may dispense, AID medications for self-administration by the patient. The Illinois Healthcare Right of Conscience Act applies to and is incorporated into the Act. HCEs may decline to provide AID services, and may restrict their employed or contracted HCPs from providing them while engaged in work for the HCE. HCPs may also decline to participate in AID services. HCEs may not restrict their HCPs from providing AID services in a practice setting independent of the HCE. HCEs must cooperate with a requested transfer of care and may not restrict their HCPs from providing information to patients about AID services or community resources. The Act contains numerous definitions, detailed requirements and additional provisions not described in this summary. The Illinois Department of Public Health and the Department of Veterans Affairs are authorized to promulgate rules to assist in the implementation and administration of the Act. In ascertaining their rights and obligations, providers should carefully examine the full text of the Act and any rules that are issued. Future articles are planned that will summarize specific aspects of the Act in greater detail and discuss some of the issues and steps that an affected provider should consider. ]]>